Eagle Wealth Advisors’s Amgen AMGN Stock Holding History

Eagle Wealth Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$606K	Buy	1,673 +280	+20%	+$95.8K	0.46%	44
2026 Q1	$490K	Buy	+1,393	New	+$497K	0.45%	46

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Eagle Wealth Advisors's AMGN Position: Q2 2026 in Review

Eagle Wealth Advisors increased its Amgen (AMGN) stake by 20% in Q2 2026, buying an estimated $95.8K and bringing the position to 1,673 shares worth $606K. The position accounts for 0.46% of the portfolio, ranked #44.

Eagle Wealth Advisors first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Eagle Wealth Advisors held 1,673 shares of Amgen worth $606K as of Q2 2026.
Eagle Wealth Advisors bought 280 Amgen shares in Q2 2026, an estimated $95.8K.
Amgen made up 0.46% of Eagle Wealth Advisors's portfolio in Q2 2026, its #44 holding.
Eagle Wealth Advisors first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Eagle Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.